Press releases // 16 December 2014
Collaboration with PICCOLO study investigators for miR-31-3p

IntegraGen has announced a collaboration with the team of investigators from the PICCOLO study to further validate the role of biomarker hsa-miR-31-3p in metastatic colorectal cancer (mCRC).